A multifaceted intervention to improve bleeding management among patients using oral anticoagulants (IMPACT-BLEEDING)

Trial Identifier: D9603R00021
Sponsor: AstraZeneca
Start Date: January 2025
Primary Completion Date: January 2025
Study Completion Date: January 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

No locations posted.